Stay Up-to-Date With COVID-19 Vaccine Development
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 25 minutes
Science is facing, arguably, one of its greatest challenges yet – the COVID-19 outbreak. Scientists across the globe are working tirelessly to understand the virus at a molecular level; how it survives, mutates, spreads and infects humans. Collectively, these efforts enhance our ability to develop both preventive and therapeutic strategies against SARS-CoV-2. Vaccines are an example of one such preventive.
Technology Networks is committed to keeping you updated with the latest research in this space. Below, you'll find a curation of our latest COVID-19 vaccine-related content.
Latest COVID-19 vaccine video interviews:
Latest COVID-19 vaccine infographics:
The global response to the COVID-19 pandemic has included the development and authorization of a growing number of vaccines. How do they compare?
Download this infographic to find out more.
Accelerate your efforts to combat infectious disease
Addressing the threat of new and potentially life-threatening pathogens requires deep understanding and accurate, reproducible techniques for developing better tests, vaccines, and treatments. Agilent provides the complete breadth of systems, consumables, software, services, and knowledge you need to support your success.
Learn more!Sponsored Content
Latest COVID-19 vaccine news and article coverage:
- Building Better Vaccines for SARS-CoV-2
- FDA Approves Pfizer COVID-19 Vaccine
- Vaccine Efficacy Against Different SARS-CoV-2 Variants
- Cross-Neutralizing Activity Found in Pfizer Jab Recipients That Had 2003 SARS
- Early COVID-19 Vaccine Campaign in the US Prevented Nearly 140,000 Deaths
- Developing Better Intranasal Vaccines for COVID-19 and Flu
- Delta Variant Unable To Evade Antibodies Induced by COVID-19 Vaccination
- Pregnant Women Tolerate COVID-19 Vaccines Well
- Meet the Scientist Couple Driving an mRNA Vaccine Revolution
- Simple Addition to COVID-19 Vaccines Could Enhance Their Effectiveness
- Intranasal COVID-19 Vaccine Reduces Disease Severity and Blocks Transmission
- New Light on Rare Cases of Blood Clotting Following COVID-19 Vaccination
- Ideas for a Pan-Coronavirus Vaccine
- Flu Shot Protects Against Severe Effects of COVID-19
- 16 and 17-Year-Olds To Receive First Dose of Pfizer Vaccine in the UK
- UK Administers Over 85 Million COVID-19 Vaccines
- One Billion Doses of Oxford COVID-19 Vaccine Have Been Released
- Study Will Test Different Time Intervals for COVID-19 Vaccines in Pregnant Individuals
- To Avoid Vaccine Hesitance, Emphasize Personal Health Benefits of COVID-19 Vaccination
- Vaccine Antibody Levels Start To Decline After 2–3 Months
- Developing Thermostable Vaccines To Improve Accessibility Worldwide
- mRNA COVID-19 Vaccines: Safety of Second Dose Following First-Dose Allergic Reactions
- Advantages of Intranasal Delivery of COVID-19 Vaccines
- Pfizer COVID-19 Vaccine 78% Effective in Pregnant Women
- Vaccine Passports Raise Equity Concerns
- mRNA From COVID-19 Vaccine Is Not Transferred Through Mother’s Breast Milk
- Are Biomaterial Vaccines on the Horizon?
- mRNA Vaccine Recipients Are 91% Less Likely To Develop COVID-19
- A Vaccine for All Coronaviruses
- mRNA COVID-19 Vaccines Prime T Cells To Fight Against SARS-CoV-2 Variants
- mRNA COVID-19 Vaccines Generate Germinal Centers Important for Lasting Immunity
- Study of COVID-19 Vaccination During Pregnancy and Postpartum Begins
- COVID-19 Vaccines Pre-Prepared in Syringes Can Be Safely Transported
- CureVac's COVID-19 Vaccine Demonstrates Interim Efficacy of 47%
- COVID-19: Vaccines, Pregnancy, Menstruation, Breastfeeding and Fertility
- Novavax COVID-19 Vaccine Demonstrates an Overall Efficacy of 90.4%
- Addressing Racial Disparities in COVID-19 Vaccination
- Janssen COVID-19 Vaccine Generates Immune Response Against Variants
- Examining Risk–Benefit Profiles for Vaccines
- COVID-19 Vaccine Safety in Pregnancy
- UK Authorizes Pfizer COVID-19 Vaccine for 12 to 15-Year-Olds, but They May Not Be Offered It
- Changing Up the Route of Vaccine Administration
- Why mRNA Vaccines Could Be a Game Changer
- COVID-19 Vaccine and Periods
- Blood Test Confirms mRNA Vaccine Activates Robust Immune Response
- Moderna’s COVID-19 Vaccine Is Safe and Effective in Adolescents
- The Ethics and Safety of COVID-19 Vaccine Passports
- A Link Between Reduced Leptin Levels and Vaccine Response
- Delaying Second Dose of Pfizer COVID-19 Vaccine Increases Antibody Response in the Elderly
- COVID-19 Vaccine Storage and Stability
- A New Way of Predicting COVID-19 Vaccine Efficacy
- Delaying Second COVID-19 Vaccine Dose May Prevent Deaths, Under Certain Conditions
- Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents
- Mixing COVID-19 Vaccines Increases Side Effects, Preliminary Data Suggests
- Study Finds COVID-19 Vaccines Do Not Damage the Placenta in Pregnancy
- Toxicity Studies in Vaccine Clinical Development and Registration
- Pan-Coronavirus Vaccine Blocks SARS-CoV-2 and Variants in Animal Study
- The “Key” to COVID-19 Vaccine Development Lies in the Way the Virus Binds to Human Cells
- COVID-19 Vaccine Prioritization and the Impact of Non-Pharmaceutical Interventions
- Vaccine Production: Navigating Scale-Up Challenges
- What the COVID-19 Pandemic Taught Us About Flexibility in Vaccine Manufacturing
- UK Administers 50 Million Doses of COVID-19 Vaccine
- Single Dose of COVID-19 Vaccine Boosts Protection Against Variants, but Only in Those With Prior Infection
- Modeling Study Shows High Vaccination Rate Is Key to Course of COVID-19 Pandemic
- One in Four People Experience Mild Side Effects From COVID-19 Vaccines
- UK’s Preference for AstraZeneca COVID-19 Vaccine Has Declined, but Vaccine Confidence Levels Are Up
- Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of COVID-19 Vaccine
- COVID-19 Vaccine Effectiveness Confirmed in Specific Sub-Populations
- Why COVID-19 Vaccine Side Effects May Feel Worse After the Second Dose
- Second COVID-19 Vaccine Important for Those Who Have Not Had the Disease
- UK Government-Funded COVID-19 Vaccine Phase I/II Trials Report Positive Data
- Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine
- COVID-19: Therapeutics, Preventives and Industry Perspectives
- The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine
- Oxford–AstraZeneca COVID-19 Vaccine: Regulators Give Update on Links to Rare Clotting Disorders
- New Survey Highlights Public Support for Donation of COVID-19 Vaccines to Low-Income Countries
- Clinical Trial To Explore Allergic Reactions to Moderna, Pfizer–BioNTech COVID-19 Vaccines Begins
- The Long Run: Keeping an Eye on COVID-19 Vaccines
- Moderna COVID-19 Vaccine Rollout Commences in the UK
- Clinical Trial Evaluating COVID-19 Variant Vaccine Begins
- Time-Temperature Indicator Could Monitor the Storage Conditions of mRNA Vaccines
- New Data Suggests UK’s COVID-19 Vaccination Program Has Prevented Thousands of Elderly Deaths
- Vaccine Passports: More Problematic Than Useful?
- Will COVID-19 Vaccines Need To Be Evaluated and Adapted Regularly?
- Why Do COVID-19 Vaccines Cause Side Effects?
- How Do the Leading COVID-19 Vaccines Work?
- Real-World Data Shows Benefit of Early Vaccination on Health Care Workforce
- Oxford–AstraZeneca Vaccine Is Safe and Highly Effective, Phase III Study Finds
- Oxford–AstraZeneca Vaccine Not Associated With Overall Risk of Thromboembolic Events, Says EMA
- New Study Provides Global Analysis of COVID-19 Vaccines
- Oxford–AstraZeneca COVID-19 Vaccination Pause: What's the Story?
- Novavax Announces COVID-19 Vaccine Has High Efficacy Against SARS-CoV-2 and Variant Strains
- Harnessing Measles Vaccine’s Successful History To Protect Against SARS-CoV-2
- Single Dose of Pfizer or Oxford Vaccine May Significantly Reduce Risk of Elderly COVID-19 Hospitalizations
- New Study Predicts SARS-CoV-2 Evolving To Escape Current Vaccines
- SARS-CoV-2 Variants Can Evade Antibodies That Neutralize Original Virus
- The COVID-19 Whack-a-Mole
- A New Nanotechnology-Based COVID-19 Vaccine Candidate
- Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose
- Pfizer COVID-19 Vaccine Provokes Immune Response in Those Previously Infected
- WHO Says Oxford’s Vaccine Is Safe and Likely to Be Efficacious in Older Adult
- First-of-its-Kind Study Will Test Combination of Different COVID-19 Vaccines
- Over 10 Million People Receive First Dose of COVID-19 Vaccine in UK
- Different Types of COVID-19 Vaccines With Dr Seth Lederman
- New Platform Can Quickly Make Vaccines at the Point-of-Care
-Allergists Stress That COVID-19 Vaccine Can Be Administered to People With Allergies
-COVID-19 Candidate Vaccine Progresses to Phase 1 Clinical Trials
-COVID-19 Candidate Vaccine Progresses to Phase 1 Clinical Trials
-The Global Push for a COVID-19 Vaccine
-Teach Me in 10 – How Can Plants Be Used To Fight COVID-19? With Dr Kathleen Hefferon
-Teach Me in 10 – How Can Plants Be Used To Fight COVID-19? With Dr Kathleen Hefferon
-Looking Beyond the Spike Protein for SARS-CoV-2 Vaccine Design
-Significant Public Messaging Required Before COVID-19 Vaccines Are Made Available, Study Says
-Johnson & Johnson Temporarily Pauses COVID-19 Vaccine Clinical Trials
-BCG Vaccine Does Not Protect Against COVID-19, Data Suggests
-Clinical Trial Will Test Inhalation of Two Coronavirus Vaccines Currently in Development
-3 in 10 Americans Unwilling To Get a COVID-19 Vaccine, Survey Finds
-Clinical Trial Will Test Inhalation of Two Coronavirus Vaccines Currently in Development
-3 in 10 Americans Unwilling To Get a COVID-19 Vaccine, Survey Finds
-Biopharma CEOs Unite To Sign Pledge for COVID-19 Vaccine
-Pausing of Oxford's COVID-19 Vaccine Trial Is "Routine Action"
-Research Team Lay Groundwork for Fair Distribution of a COVID-19 Vaccine
-Pausing of Oxford's COVID-19 Vaccine Trial Is "Routine Action"
-Research Team Lay Groundwork for Fair Distribution of a COVID-19 Vaccine
-Vaccine Shows Protection Against SARS-CoV-2 in Animals
-Russia Publishes First Clinical Data on "Already Approved" COVID-19 Vaccine
-Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins
-Misinformed Vaccine Views Could Fuel Policy Headaches
-Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
- Scripps Research Spin-Off Ushers a "New Era" in Vaccinology With Platform Technology
-Russia Publishes First Clinical Data on "Already Approved" COVID-19 Vaccine
-Phase III Testing of AstraZeneca COVID-19 Vaccine Candidate Begins
-Misinformed Vaccine Views Could Fuel Policy Headaches
-Biomaterial-Based Vaccine That Sits Under the Skin Shows Promise Against SARS-CoV-2
- Scripps Research Spin-Off Ushers a "New Era" in Vaccinology With Platform Technology
-Washington University COVID-19 Vaccine Effective in Mice
-Russia’s COVID-19 Vaccine “Approved" Despite No Phase III Data
-Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
-Phase II/III Clinical Trial for COVID-19 Vaccine Begins at NYU Langone Health
-Phase III Clinical Trial of COVID-19 Vaccine Begins
-Database Offers Access to 200 Million Immune Sequences From COVID-19 Patients
-Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing
-Oxford Coronavirus Vaccine Produces Strong Immune Response, Early Results Indicate
-Vaccine Response-enhancing Additive Has Implications for SARS-CoV-2
-Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
-Sinovac COVID-19 Vaccine Collaboration Receives Approval for Phase III Trial
-Optimizing the Discovery of Synthetic Antibodies for SARS-CoV-2
-Controlled Human Infection Models for SARS-CoV-2 Vaccine Development
-13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
-Scientists Suggest That Childhood Vaccines Could Protect Against COVID-19
-First Volunteer Receives Imperial COVID-19 Vaccine
-Vaccine Against COVID-19 Advances to Late-stage Development
-GSK and Clover Biopharmaceuticals COVID-19 Vaccine Begins Human Clinical Trials
-Researchers Propose a Clinical Trial To Test MMR Vaccine for COVID-19
-Cobra Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate
-Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
-Industry Leaders Provide An Update on COVID-19 Vaccine Progress
-Oral Vaccine for COVID-19 On Track Towards Human Clinical Trials
-Phase I/II Clinical Trial of COVID-19 Vaccine Begins
-Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2
-Funding Boost for UK Vaccine Programme
-Analysis of SARS-CoV-2 Immune Response Bodes Well for Vaccine Development
-CEPI Extends Collaboration With Novavax To Advance Development and Manufacture of COVID-19 Vaccine
-Key Challenges in COVID-19 Vaccine Development Outlined
-Scientists Team Up To Create A Strategic Plan for COVID-19 Vaccine R&D
-Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2
-Positive Pre-clinical Data for Oral COVID-19 Vaccine Program
-SARS-CoV-2 Antibody Screening Trials To Aid Quest for Vaccine
-Novel Gene-based Vaccine Candidate Against SARS-CoV-2 in Development
-CEPI Announces a Ninth COVID-19 Vaccine Development Partnership
-Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete
-Meet the Subjects of the UK's First Coronavirus Vaccine Clinical Trial
-Inside the UK's Coronavirus Vaccine Clinical Trial
-University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials
-New Partnership To Develop a Pan-Coronavirus DNA Vaccine
-MERS Vaccine Clinical Trial Offers Useful Insights for SARS-CoV-2 Vaccine Development
-First New Oral Polio Vaccine in 50 Years Offers Lessons for COVID-19
-UK Human Clinical Trials of COVID-19 Vaccine Set To Begin
-Preprint Suggests MERS-CoV Vaccine Can Protect Monkeys
-Consortium Members Work To Deliver UK's First COVID-19 Vaccine As Quickly and Safely As Possible
- CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine
- Collaboration To Develop Gene-encoded Antibody Vaccine Against COVID-19 Is Underway
-Optimizing the Discovery of Synthetic Antibodies for SARS-CoV-2
-Controlled Human Infection Models for SARS-CoV-2 Vaccine Development
-13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
-Scientists Suggest That Childhood Vaccines Could Protect Against COVID-19
-First Volunteer Receives Imperial COVID-19 Vaccine
-Vaccine Against COVID-19 Advances to Late-stage Development
-GSK and Clover Biopharmaceuticals COVID-19 Vaccine Begins Human Clinical Trials
-Researchers Propose a Clinical Trial To Test MMR Vaccine for COVID-19
-Cobra Signs Supply Agreement with AstraZeneca for Manufacture of COVID-19 Vaccine Candidate
-Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
-Industry Leaders Provide An Update on COVID-19 Vaccine Progress
-Oral Vaccine for COVID-19 On Track Towards Human Clinical Trials
-Phase I/II Clinical Trial of COVID-19 Vaccine Begins
-Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2
-Funding Boost for UK Vaccine Programme
-Analysis of SARS-CoV-2 Immune Response Bodes Well for Vaccine Development
-CEPI Extends Collaboration With Novavax To Advance Development and Manufacture of COVID-19 Vaccine
-Key Challenges in COVID-19 Vaccine Development Outlined
-Scientists Team Up To Create A Strategic Plan for COVID-19 Vaccine R&D
-Custom Lentivirus Pseudotyped with Spike Glycoprotein from SARS-CoV-2
-Positive Pre-clinical Data for Oral COVID-19 Vaccine Program
-SARS-CoV-2 Antibody Screening Trials To Aid Quest for Vaccine
-Novel Gene-based Vaccine Candidate Against SARS-CoV-2 in Development
-CEPI Announces a Ninth COVID-19 Vaccine Development Partnership
-Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete
-Meet the Subjects of the UK's First Coronavirus Vaccine Clinical Trial
-Inside the UK's Coronavirus Vaccine Clinical Trial
-University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials
-New Partnership To Develop a Pan-Coronavirus DNA Vaccine
-MERS Vaccine Clinical Trial Offers Useful Insights for SARS-CoV-2 Vaccine Development
-First New Oral Polio Vaccine in 50 Years Offers Lessons for COVID-19
-UK Human Clinical Trials of COVID-19 Vaccine Set To Begin
-Preprint Suggests MERS-CoV Vaccine Can Protect Monkeys
-Consortium Members Work To Deliver UK's First COVID-19 Vaccine As Quickly and Safely As Possible
- CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine
- Collaboration To Develop Gene-encoded Antibody Vaccine Against COVID-19 Is Underway
- Using Fast-growing Tobacco Plants To Develop a COVID-19 Vaccine
-Vaccine and Drug Development for COVID-19 – When the Cure Becomes the Problem
-Genetic System Can Reduce COVID-19 Vaccine Development Timeframe
-Which Vaccines Against COVID-19 Are in Human Clinical Trials?
- Progressing Towards a COVID-19 Vaccine
-COVID-19 Vaccine Development: An Interview With GeoVax
- Vaccine in Development for COVID-19 Using Fast-growing Tobacco Plant Tech
- COVID-19: Exploring Industry Efforts and Collaborations
- Sartorius Supports COVID-19 Vaccine Development Efforts
- COVID-19 – Accelerating Vaccine Development and Manufacturing
-COVID-19 Vaccine Development Update: An Interview With Novavax
- $12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts
- Mapping Out Data Requirements for Phase 1 COVID-19 Vaccine Trials
- Current Efforts in COVID-19 Vaccine Development
- Phase 1 Clinical Trial of Coronavirus Vaccine Commences
- Are Coronavirus Vaccines and Therapeutics Waiting in the Wings?
- Structural Biology Helps Drive Coronavirus Vaccine Development
- New Coronavirus Insights Mark Important Step Towards Vaccine
-Vaccine and Drug Development for COVID-19 – When the Cure Becomes the Problem
-Genetic System Can Reduce COVID-19 Vaccine Development Timeframe
-Which Vaccines Against COVID-19 Are in Human Clinical Trials?
- Progressing Towards a COVID-19 Vaccine
-COVID-19 Vaccine Development: An Interview With GeoVax
- Vaccine in Development for COVID-19 Using Fast-growing Tobacco Plant Tech
- COVID-19: Exploring Industry Efforts and Collaborations
- Sartorius Supports COVID-19 Vaccine Development Efforts
- COVID-19 – Accelerating Vaccine Development and Manufacturing
-COVID-19 Vaccine Development Update: An Interview With Novavax
- $12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts
- Mapping Out Data Requirements for Phase 1 COVID-19 Vaccine Trials
- Current Efforts in COVID-19 Vaccine Development
- Phase 1 Clinical Trial of Coronavirus Vaccine Commences
- Are Coronavirus Vaccines and Therapeutics Waiting in the Wings?
- Structural Biology Helps Drive Coronavirus Vaccine Development
- New Coronavirus Insights Mark Important Step Towards Vaccine
Meet the Authors
Managing Editor
Senior Science Writer
